NCT06758271Recruiting
Special Drug Use-results Survey for Long-term Use（Avacopan）
Special Drug Use-results Survey for Long-term Use
Source: ClinicalTrials.gov · Last updated 17 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 26 Dec 2024
- Start date
- 29 Jul 2022
- Primary completion date
- 31 May 2028
- Lead sponsor
- Kissei Pharmaceutical Co., Ltd.
- Diseases
- ANCA-associated vasculitis
- NCT number
- NCT06758271
What you commit to
- Study type: Observational
- Planned participants: 250
- From 29 Jul 2022 to the primary completion date, 31 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Research Site Coordinator of this site? Confirm its status | Multiple Locations | Japan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.